logo-loader
viewTrutrace Technologies Inc.

TruTrace Technologies signs deal to provide technology to Zenabis Global

TruTrace Technologies (CSE:TTT) CEO Robert Galarza joined Steve Darling from Proactive Investors Vancouver on Skype to talk about a new deal the company has just signed. TruTrace now working with Zenabis Global who will employ Trutrace's StrainSecure platform to collect, register, manage, track and publish verified testing data of its cannabis plant DNA and strains.

Galarza also telling Proactive about another company, Shivon Ventures, who TruTrace,  plans on having an ongoing working relationship with.

Quick facts: Trutrace Technologies Inc.

Price: 0.05 CAD

CSE:TTT
Market: CSE
Market Cap: $4.16 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Trutrace Technologies Inc. named herein, including the promotion by the Company of Trutrace Technologies Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TruTrace Technologies ready to focus attention on generating...

TruTrace Technologies (CSE: TTT) CEO Robert Galarza joined Steve Darling from Proactive Vancouver with new the company the has completed their beta testing with Shoppers Drug Mart and he talks about what is next.   Galarza also discussed turning his attention to revenue and what markets...

on 9/1/20

2 min read